Advances in prevention and health services delivery 2009.
Goldstein
Larry B
LB
Department of Medicine (Neurology), Duke Stroke Center, Center for Clinical Health Policy Research, Duke University, Veterans Administration Medical Center, Durham, NC, USA. golds004@mc.duke.edu
Rothwell
Peter M
PM
D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use; D016893:Carotid Stenosis / Q000503:physiopathology / Q000601:surgery; D003695:Delivery of Health Care / Q000379:methods* / Q000639:trends*; D006297:Health Services Accessibility / Q000706:statistics & numerical data* / Q000639:trends*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D020767:Intracranial Thrombosis / Q000188:drug therapy / Q000503:physiopathology / Q000517:prevention & control; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D018570:Risk Assessment; D020521:Stroke / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control*; D014656:Vascular Surgical Procedures / Q000009:adverse effects / Q000379:methods / Q000639:trends
D000925:Anticoagulants; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors